title: The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy.
authors.forename: D C
authors.initials: DC
authors.lastname: Melvin
authors.forename: J K
authors.initials: JK
authors.lastname: Lee
authors.forename: E
authors.initials: E
authors.lastname: Belsey
authors.forename: J
authors.initials: J
authors.lastname: Arnold
authors.forename: R L
authors.initials: RL
authors.lastname: Murphy
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D016022:Case-Control Studies; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology
chemical_list: D019380:Anti-HIV Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase